Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin and Paclitaxel in mCRPC Post-Docetaxel
NCT01558492Phase 2Terminated
- Sponsor
- Weill Cornell Medicine
- Start
- Mar 2011
- Primary completion
- Jun 2012
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin, Paclitaxel Micelles for Injection in prostate cancer (PCa), sponsored by Weill Cornell Medicine. Started Mar 2011; status: terminated.
02
Drugs
carboplatinPaclitaxel Micelles for Injection
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01558492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01558492.